Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Nidek's OPD (Optical Path Difference)-Scan system:

This article was originally published in Clinica

Executive Summary

Nidek has received US FDA 510(k) marketing clearance for its stand-alone device for generating refractive eye maps. The OPD (Optical Path Difference)-Scan diagnostic system can create refractive power maps that show the total optical system aberrations within both eyes, claims the Fremont, California company. The product allows doctors to use one machine to create comprehensive, refractive power maps that are normally produced using at least two tests on two different machines, says Nidek's general manager and vice-president, Hiroshi Okada.

Topics

UsernamePublicRestriction

Register

MT070792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel